glp-1 trump deal Pharmacy Pricing Update (Dec 2025) White House Deal With Eli

[4] Conditions that match a drugs FDA approval generally qualify, whether youre using these major GLP-1 brands or similar: Ozempic/Mounjaro: type 2 diabetes [5] Wegovy/Zepbound: obesity (BMI 30) [6] Wegovy/Zepbound: overweight with at least one weight-related condition (BMI 27 to under 30 plus hypertension, high cholesterol, sleep apnea, cardiovascular disease, or type 2 diabetes) [7] Zepbound: obstructive sleep apnea [8] Wegovy: metabolic-associated steatohepatitis (MASH) [9] Off-label conditions can count too when your clinician documents a real diagnosis such as prediabetes, binge eating disorder, or PCOS

For the safety and well-being of pregnant and nursing women, we do not recommend the use of our patches during this period

These findings indicate a shift toward lower inflammatory signaling and improved vascularimmune regulation

& Michalopoulos, G